Melanie Butler-Gauthier, MS
Senior Consultant
Melanie Butler-Gauthier provides technical, regulatory, and strategic support for pharmacology and toxicology studies, with expertise in the nonclinical development of cell and gene therapy products. She has experience in nonclinical project management, outsourcing support, study monitoring, scientific data analysis and interpretation, as well as scientific nonclinical sections for regulatory submissions. Prior to joining SciLucent, Melanie primarily worked for biotechnology organizations developing cell and gene therapies for immuno‑oncology, cardiovascular, and rare disease indications. Melanie has a BS in Microbiology from California Polytechnic State University and an MS in Pharmacology & Toxicology from Michigan State University.
